Sourasky Medical Center (Ichilov)
| イスラエル | トルコ | オーストリア | |
| 骨髄移植術 | から $79,000 | から $36,000 | から $140,000 |
| 非血縁者間同種骨髄移植術 | から $135,000 | から $80,000 | から $180,000 |
| 同種骨髄移植術 | から $142,000 | から $65,000 | から $150,000 |
Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.
He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.
He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.
His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.
Primary treatment for aplastic anemia in Israel centers on bone marrow transplantation and advanced immunosuppressive therapy. JCI-accredited facilities provide allogeneic transplants from both related and unrelated donors. Specialized protocols include ATG, cyclosporine, and Eltrombopag for refractory cases. High success rates are supported by precise HLA matching and molecular diagnostics.
Bookimed Expert Insight: Israeli centers offer a significant advantage in donor matching through international registry access and specialized pediatric expertise. For example, Dr. Ronit El Hasid at Sourasky Medical Center has performed over 300 pediatric transplants. At Sheba Medical Center, packages around $160,000 include extensive 30-day hospitalizations. This level of integrated care is critical because recovery requires intensive monitoring that shorter stays may not provide.
Patient Consensus: Patients note it is important to start HLA typing immediately to speed up the transplant process. Many emphasize that while fatigue during recovery is challenging, having a strong support network helps manage long-term monitoring needs.
Israeli hospitals like Sourasky Medical Center, Sheba Medical Center, and Hadassah Medical Center are world leaders in treating aplastic anemia. These JCI-accredited facilities specialize in allogeneic bone marrow transplants and advanced immunosuppressive therapy. They achieve success rates reaching 90% for complex hematological cases.
Bookimed Expert Insight: Choosing between top centers often comes down to specific pediatric expertise versus adult volume. While Sheba Medical Center serves over 1,500,000 global patients annually, Sourasky offers highly specialized pediatric care at Dana-Dwek. Dr. Ronit El Hasid at Sourasky has performed over 300 successful transplantations specifically for children. Patients should compare these volume-based success rates when selecting a facility for rare blood disorders.
Patient Consensus: Patients note that Israeli hospitals excel at finding matches through international registries. They also emphasize the importance of having a translator to help navigate the intake process and hospital bureaucracy.
Israeli medical centers report survival rates exceeding 90% for bone marrow transplantation in young aplastic anemia patients. Success stays near 90.8% for those under age 40. Specialized protocols for alternative donor types maintain outcomes as high as 94% in leading facilities.
Bookimed Expert Insight: Israeli hematology departments offer a significant advantage through high-volume specialization. For example, Dr. Ivetta Danylesko at Sheba Medical Center has performed 3,000 procedures. This level of individual experience often correlates with the high survival rates reported across the country's major JCI-accredited institutions.
Patient Consensus: Patients emphasize that bone marrow transplant is often the preferred first-line treatment over immunosuppression for younger people. Many note that blood counts typically begin to normalize by day 100 with proper monitoring.
Hospitalization for a bone marrow transplant in Israel typically lasts 30 days. Patients remain in specialized HEPA-filtered rooms to prevent infections while the new immune system develops. Full physical recovery and immune rebuilding generally require 3 to 12 months of follow-up care.
Bookimed Expert Insight: While many focus on the surgery, the 30-day hospital stay included in Sheba Medical Center packages is a critical safety benchmark. High-volume centers like Sourasky, which serves over 400,000 patients annually, use this extended period to manage the delicate transition before home discharge. Selecting a package that builds in 4 weeks of inpatient care ensures professional monitoring during the highest-risk window for rejection.
Patient Consensus: Patients note it is important to pack for at least 6 weeks of hospital stay to stay comfortable. Many emphasize that recovery is not always a straight line, as the first 100 days require constant bloodwork and home help.
Candidacy for aplastic anemia treatment in Israel depends on donor availability, patient age, and disease severity. Patients under 40 with a matched sibling donor typically receive bone marrow transplants as a curative first-line therapy. Immunosuppressive therapy serves as the primary alternative when no related donor is identified.
Bookimed Expert Insight: While many believe international registries are the only option, top Israeli centers like Sheba and Rambam maintain advanced facilities for bone marrow cell collection and storage. This infrastructure allows for a more flexible transition from drug therapy to transplant if initial treatments do not produce a 90% success rate. Clinics like Sourasky Medical Center also offer specialized pediatric protocols, where Dr. Ronit El Hasid has performed over 300 successful transplants, often combining standard care with newer medications to improve outcomes.
Patient Consensus: Patients emphasize the necessity of completing a full donor search, including both siblings and global registries, before starting drug therapy. Many note that delays in medication availability can sometimes make a transplant the faster and more reliable recovery path.
International patients have full access to donor matching and unrelated-donor searches in Israel through the World Marrow Donor Association. Israeli centers routinely coordinate with global registries like the National Marrow Donor Program to identify compatible donors worldwide. This process ensures high-quality matching for complex cases.
Bookimed Expert Insight: While many search processes take months, Israeli hospitals like Sheba and Sourasky serve over 1.5 million patients annually, giving them immense logistical leverage. Our data shows that top-tier packages, which cost around $150,000 to $160,000, often include extensive diagnostics and 30-day hospital stays. High-volume centers like Sheba pioneered cord-blood transplants, providing a vital alternative when a 10/10 unrelated donor match is unavailable through standard registries.
Patient Consensus: Patients note it is vital to start the unrelated-donor search immediately through home registries to speed up acceptance at Israeli centers. Coordination with local international programs helps manage the 6–8 month lead time and logistics for 10/10 matches.
Post-treatment follow-up for aplastic anemia includes coordinated care between Israeli hematologists and local providers. Patients undergo frequent blood panels and bone marrow biopsies to monitor for relapse. Institutions like Sheba Medical Center and Hadassah Medical Center utilize telemedicine to review progress and adjust medications remotely.
Bookimed Expert Insight: While major centers like Sourasky or Hadassah provide comprehensive discharge summaries, the actual coordination often depends on the specific specialist. Dr. Ron Ram at Sourasky and Dr. Polina Stepensky at Hadassah are known for managing complex transplant protocols. Their patients should confirm follow-up visit inclusions in their $150,000 to $160,000 packages, as these often cover the first critical post-operative reviews within Israel before departure.
Patient Consensus: Patients note it is important to track your own labs and keep copies of all blood work. They emphasize establishing a local hematologist before leaving Israel for seamless care.
Sheba Medical Center and Sourasky Medical Center specialise in treating aplastic anaemia through advanced haematology institutes. These JCI-accredited facilities offer immunosuppressive therapy and allogeneic bone marrow transplants. Specialist teams manage diagnosis, marrow biopsies, and long-term infection control for complex bone marrow failure cases in Israel.
Bookimed Expert Insight: Israeli haematology centres like Sheba and Hadassah are world leaders in cellular therapies. Sheba alone treats 2,000,000 patients annually and provides on-site CAR-T manufacturing. This high volume and technical infrastructure allow specialists to manage rare bone marrow failures that smaller units cannot handle.
Patient Consensus: Patients note that successful treatment in Israel requires finding centres with strong stem cell transplant teams. They emphasise that managing infection and blood product support during long stays is as vital as the surgery itself.
Israeli clinics treat aplastic anaemia through bone marrow transplantation, immunosuppressive therapy, and biological agents. JCI-accredited centres like Sheba Medical Center use advanced HLA matching for related and unrelated donor transplants. Care protocols include high-dose medications to stop immune systems from attacking bone marrow stem cells.
Bookimed Expert Insight: Israeli oncology centres demonstrate exceptional depth in complex bone marrow cases. Dr Ronit El Hasid at Sourasky Medical Center has conducted over 300 paediatric transplants. This high volume often leads to more precise donor matching and better management of post-transplant care than lower-volume regional hospitals.
Patient Consensus: Patients in Israel emphasise that treatment is a long journey requiring a high-quality haematology team. They note that having strong infection-management setups and clear donor search timelines in English is vital for managing the condition safely.
Leading Israeli haematologists for aplastic anaemia include Prof. Ron Ram and Prof. Ronit El Hasid at Sourasky Medical Center, and Prof. Amos Toren at Sheba Medical Center. These specialists focus on bone marrow transplantation and advanced immunosuppressive therapies. They operate within JCI-accredited facilities that handle complex blood marrow failure cases.
Bookimed Expert Insight: Israeli haematology units operate at high volumes. Sheba Medical Center alone serves nearly 2,000,000 patients annually. This massive scale ensures doctors see rare conditions like aplastic anaemia frequently. Specialists here often hold multiple advanced degrees. For instance, Prof. Amos Toren holds an MD, PhD, and MHA. This deep academic background speeds up the path from diagnosis to complex transplant.
Patient Consensus: Patients note it's important to choose big university hospitals for allogeneic transplants and fast donor typing. They suggest bringing all original pathology slides and transfusion records to the first appointment in Israel.
Treatment for aplastic anemia in Israel typically involves a 30-day hospital stay for bone marrow transplantation. Full immune recovery often takes 6 to 12 months. Patients undergo intensive diagnostics followed by a 30-day isolation period to monitor for engraftment and prevent infection.
Bookimed Expert Insight: Israeli hospitals like Sheba Medical Center and Sourasky Medical Center are global leaders. Sheba is a Newsweek-ranked Top-10 global hospital. These centres specialise in complex pediatric cases. Dr Amos Toren and Dr Ronit El Hasid are internationally recognised. Their experience with over 300 transplants provides a safety net for difficult cases. Australian families benefit from the English-speaking coordinators and translated medical documents provided by these dedicated international departments.
Patient Consensus: Treatment is a long-haul process. Recovery milestones like stabilizing immune function happen in separate phases. Patients note that early weeks feel slow, even when labs show progress. Daily life often revolves around transfusion support and strict infection precautions like wearing masks. Energy levels might lag behind blood count improvements for several months in Israel.
Israeli hospitals provide international patient departments that manage administrative and logistical workloads. These teams coordinate pre-arrival medical reviews and visa facilitation. Leading facilities like Sheba Medical Center offer dedicated coordinators and airport-clinic-airport transfers. Specialists provide remote consultations and tailored treatment programs for foreign patients.
Bookimed Expert Insight: Israeli oncology and haematology packages often bundle extensive diagnostics and full-board accommodation. For example, Sheba Medical Center packages frequently include 30 days of hospitalization and 24-hour nursing care. Such comprehensive inclusions are rare globally and provide significant value for complex bone marrow transplants.
Patient Consensus: Patients note that international departments provide fast access to specialists. They recommend establishing clear follow-up plans with Australian haematologists before travelling to Israel.